London Health Sciences Centre - Verspeeten Family Cancer Centre

London, Ontario N6A 5W9

1 studies enrolling now · 3 studies all time

What they study most

Migraine, NSCLC Stage IV, Pulmonary Arterial Hypertension

Studies at this site

• Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In — Recruiting now
• A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine — Running, not enrolling
• A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension — Running, not enrolling